Bejon, P., Peshu, N., Gilbert, S., Lowe, B., Molyneux, C., Forsdyke, J., . . . Marsh, K. (2006). Safety profile of the viral vectors of attenuated fowlpox strain FP9 and modified vaccinia virus Ankara recombinant for either of 2 preerythrocytic malaria antigens, ME-TRAP or the circumsporozoite protein, in children and adults in Kenya.
Chicago Style (17th ed.) CitationBejon, P., N. Peshu, S. Gilbert, B. Lowe, C. Molyneux, J. Forsdyke, T. Lang, A. Hill, and K. Marsh. Safety Profile of the Viral Vectors of Attenuated Fowlpox Strain FP9 and Modified Vaccinia Virus Ankara Recombinant for Either of 2 Preerythrocytic Malaria Antigens, ME-TRAP or the Circumsporozoite Protein, in Children and Adults in Kenya. 2006.
ציטוט MLABejon, P., et al. Safety Profile of the Viral Vectors of Attenuated Fowlpox Strain FP9 and Modified Vaccinia Virus Ankara Recombinant for Either of 2 Preerythrocytic Malaria Antigens, ME-TRAP or the Circumsporozoite Protein, in Children and Adults in Kenya. 2006.